RLI
RLI NYSE Property & Casualty Insurance Financials FY2016βFY2025
RLI's revenue rose 6.3% to $1.9 billion in fiscal 2025. Its net margin was 21.4%, up from 19.5% a year earlier. Free cash flow was $609 million, up 9.6%. It paid out $242 million in dividends and buybacks, 40% of free cash flow.
About these figures. Share counts and per-share figures for earlier years are restated for a stock split (2-for-1), so every year is on today's share basis.
What RLI does
No business description yet.
- Legal name
- RLI Corp
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001104659-26-018013
0000084246
Revenue and margins
RLI had $1.9B of revenue in fiscal 2025, up 6.3% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 14.5% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $609M in fiscal 2025, 32.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
RLI returned $242M to shareholders in fiscal 2025, 40% of free cash flow. The diluted share count fell 0.1%.
Value RLI yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β and divides by 92.4M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 15.1x Β· peers 11.5x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably RLI can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $88.8M | $22.8M | $36.4M | $39.8M | $51.6M |
| Debt incl. finance leases | $200M | $200M | $200M | β | β |
| Net debt / EBITDA | 0.3x | 0.2x | 0.4x | β | β |
| Debt / equity | 0.2x | 0.2x | 0.1x | β | β |
| Interest coverage | 45.9x | 90.6x | 52.7x | 68.5x | 95.4x |
| Total assets | $4.5B | $4.8B | $5.2B | $5.6B | $6.2B |
| Total liabilities | $3.3B | $3.6B | $3.8B | $4.1B | $4.4B |
| Shareholders' equity | $1.2B | $1.2B | $1.4B | $1.5B | $1.8B |
| Net debt (β = net cash) | $111M | $177M | $164M | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$1.3M
4 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Clark C KelloggDirector | Bought | 3,000 | $50.90 | $0.2M | Form 4 |
| May 28, 2026 | David B. DuclosDirector | Bought | 2,500 | $51.99 | $0.1M | Form 4 |
| May 27, 2026 | Craig W KliethermesChief Executive Officer | Bought | 2,000 | $52.00 | $0.1M | Form 4 |
| May 27, 2026 | Jennifer L KlobnakChief Operating Officer | Bought | 2,000 | $52.72 | $0.1M | Form 4 |
| May 21, 2026 | Craig W KliethermesChief Executive Officer | Bought | 5,000 | $52.00 | $0.3M | Form 4 |
| May 19, 2026 | Jennifer L KlobnakChief Operating Officer | Bought | 2,000 | $53.42 | $0.1M | Form 4 |
| Jan 23, 2026 | Craig W KliethermesChief Executive Officer | Bought | 5,000 | $57.45 | $0.3M | Form 4 |
| Jan 23, 2026 | Jennifer L KlobnakChief Operating Officer | Bought | 2,000 | $57.99 | $0.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β3.2% | β4.0% | β3.6% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| RLI RLI | $6.0B | 6.3% | β | 32.3% | β | 15.1x | β | |
| Kinsale Capital Group KNSL | $8.2B | 18.0% | β | 52.8% | 28.7% | 15.9x | β | Compare β |
| Selective Insurance Group SIGI | $5.8B | 9.8% | β | 22.4% | 14.6% | 11.6x | β | Compare β |
| Hanover Insurance THG | $8.5B | 5.7% | 14.2% | 17.8% | 21.3% | 11.4x | β | Compare β |
| Old Republic International ORI | $9.6B | 11.0% | β | β | β | 8.5x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $816M | $797M | $818M | $1.0B | $984M | $1.2B | $1.7B | $1.5B | $1.8B | $1.9B |
| Interest expense | $7.4M | $7.4M | $7.4M | $7.6M | $7.6M | $7.7M | $8.0M | $7.3M | $6.3M | $5.4M |
| Pretax income | $157M | $84.6M | $67.6M | $233M | $190M | $344M | $721M | $377M | $428M | $506M |
| Income tax | $42.2M | β$20.4M | $3.4M | $41.1M | $32.8M | $65.0M | $137M | $72.7M | $81.8M | $103M |
| Net income | $115M | $105M | $64.2M | $192M | $157M | $279M | $583M | $305M | $346M | $403M |
| Diluted EPS | $1.29 | $1.18 | $0.71 | $2.12 | $1.73 | $3.06 | $6.37 | $3.31 | $3.74 | $4.37 |
| Diluted shares | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B |
| Cash flow | ||||||||||
| Cash from operations | $175M | $198M | $217M | $277M | $263M | $385M | $250M | $464M | $560M | $614M |
| Capital expenditure | $16.2M | $9.2M | $6.1M | $7.0M | $5.8M | $8.3M | $5.9M | $5.9M | $4.7M | $5.5M |
| Free cash flow | $158M | $188M | $211M | $270M | $257M | $377M | $245M | $458M | $556M | $609M |
| Depreciation and amortization | $7.3M | $7.6M | $7.4M | $8.6M | $7.8M | $7.6M | $8.0M | $8.5M | $7.7M | $8.1M |
| Stock-based compensation | $4.1M | $4.4M | $4.5M | $4.5M | β | β | β | β | β | β |
| Acquisitions | $0.8M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $123M | $114M | $83.1M | $85.6M | $87.9M | $135M | $365M | $140M | $236M | $242M |
| Dividends and buybacks | $122M | $114M | $83.1M | $85.6M | $87.9M | $135M | $365M | $140M | $236M | $242M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $23.3M | $34.3M | $41.7M | $46.2M | $62.2M | $88.8M | $22.8M | $36.4M | $39.8M | $51.6M |
| Total debt | $149M | $149M | $149M | $149M | $150M | $200M | $200M | $200M | β | β |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $54.6M | $55.8M | $54.7M | $53.1M | $51.4M | $52.2M | $49.6M | $46.7M | $43.2M | $40.7M |
| Total assets | $2.8B | $2.9B | $3.1B | $3.5B | $3.9B | $4.5B | $4.8B | $5.2B | $5.6B | $6.2B |
| Total liabilities | $2.0B | $2.1B | $2.3B | $2.6B | $2.8B | $3.3B | $3.6B | $3.8B | $4.1B | $4.4B |
| Shareholders' equity | $824M | $854M | $807M | $995M | $1.1B | $1.2B | $1.2B | $1.4B | $1.5B | $1.8B |
| Margins | ||||||||||
| EBITDA margin | 21.1% | 12.5% | 10.1% | 24.8% | 20.9% | 30.5% | 43.4% | 26.0% | 24.9% | 27.6% |
| Net margin | 14.1% | 13.2% | 7.8% | 19.1% | 16.0% | 23.7% | 34.4% | 20.2% | 19.5% | 21.4% |
| FCF margin | 19.4% | 23.6% | 25.8% | 26.9% | 26.2% | 31.9% | 14.4% | 30.3% | 31.4% | 32.3% |
| Returns | ||||||||||
| Return on capital | 12.6% | 9.6% | 7.6% | 19.7% | 14.1% | 22.3% | 43.8% | 21.2% | β | β |
| Return on equity | 14.0% | 12.5% | 7.7% | 21.3% | 14.7% | 23.6% | 48.5% | 23.5% | 23.6% | 24.4% |
| Return on assets | 4.2% | 3.7% | 2.1% | 5.8% | 4.2% | 6.6% | 12.6% | 6.1% | 6.4% | 6.8% |
| Growth | ||||||||||
| Revenue growth | 2.7% | β2.3% | 2.6% | 22.7% | β2.0% | 19.9% | 44.0% | β11.0% | 17.1% | 6.3% |
| Net income growth | β16.5% | β8.6% | β38.9% | 198.6% | β18.0% | 77.8% | 108.8% | β47.8% | 13.5% | 16.7% |
| EPS growth | β17.0% | β8.9% | β39.4% | 195.8% | β18.2% | 76.6% | 108.5% | β48.0% | 13.0% | 16.8% |
| FCF growth | 11.1% | 18.9% | 12.1% | 27.9% | β4.6% | 46.3% | β35.1% | 87.4% | 21.2% | 9.6% |
| Share count change | 0.7% | 0.2% | 0.8% | 0.9% | 0.3% | 0.7% | 0.2% | 0.6% | 0.3% | β0.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.7x | 1.2x | 1.3x | 0.4x | 0.4x | 0.3x | 0.2x | 0.4x | β | β |
| Debt / equity | 0.2x | 0.2x | 0.2x | 0.2x | 0.1x | 0.2x | 0.2x | 0.1x | β | β |
| Interest coverage | 22.2x | 12.4x | 10.1x | 31.7x | 26.0x | 45.9x | 90.6x | 52.7x | 68.5x | 95.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.0% | 1.2% | 0.7% | 0.7% | 0.6% | 0.7% | 0.4% | 0.4% | 0.3% | 0.3% |
| Stock comp / revenue | 0.5% | 0.6% | 0.6% | 0.5% | β | β | β | β | β | β |
| Payouts / FCF | 77.4% | 60.5% | 39.4% | 31.7% | 34.1% | 35.9% | 149.2% | 30.6% | 42.4% | 39.7% |
| Quality scores | ||||||||||
| Accruals ratio | β2.2% | β3.2% | β5.1% | β2.6% | β2.8% | β2.5% | 7.2% | β3.2% | β4.0% | β3.6% |
Source: SEC EDGAR XBRL filings (CIK 0000084246). Data updated October 21, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.